Screening in Contract Design: Evidence from the ACA Health Insurance Exchanges

Citation:

Geruso, Mike, Tim Layton, and Daniel Prinz. Working Paper. “Screening in Contract Design: Evidence from the ACA Health Insurance Exchanges”.
PDF964 KB

Abstract:

We study insurers’ use of prescription drug formularies to screen consumers in the ACA Health Insurance Exchanges. We begin by showing that Exchange risk adjustment and reinsurance succeed in neutralizing selection incentives for most, but not all, consumer types. A minority of consumers, identifiable by demand for particular classes of prescription drugs, are predictably unprofitable. We then show that contract features relating to these drugs are distorted in a manner consistent with multi-dimensional screening. The empirical findings support a long theoretical literature examining how insurance contracts offered in equilibrium can fail to optimally trade-off risk protection and moral hazard.

Notes:

NBER Working Paper 22832
Revise and Resubmit, American Economic Journal: Economic Policy
Awarded the 2017 Mark A. Satterthwaite Award for Outstanding Research in Healthcare Markets
Summary on the Incidental Economist

Last updated on 10/11/2017